Rinvoq Copay Card: Do I qualify and how much can I save?
You may pay as little as $0 a month for your Rinvoq (upadacitinib) prescription if you qualify for the Rinvoq Complete Savings Card. To be eligible, you need to have commercial insurance (not government) and a Rinvoq prescription for an FDA approved condition.
The Rinvoq copay card has a $14,000 annual maximum benefit. Additionally, the Rinvoq Complete Rebate program covers certain lab tests where the full cost is not covered by your insurance. The maximum savings limit is $1,000 per year.
Can I use the Rinvoq Complete Savings Card if I have Medicare?
No. The Rinvoq copay card can not be used with Medicare, or any other federal or state programs such as:
- Medicare Part D
- Medigap
- Medicaid
- TRICARE
- Veterans Administration (VA)
- Dept of Defense (DOD)
The savings program also cannot be used if your insurance provider does not allow it.
If you have Medicare, you may be eligible to receive Extra Help. This is a government program that helps you pay for your prescriptions after what your plan already pays for, and your eligibility is determined by your income. To apply for Extra Help, you can call Social Security at 1-800-772-1213 or visit the website at https://secure.ssa.gov/i1020/start.
Can I get the Rinvoq copay card if I don’t have insurance?
You may be eligible for help paying for Rinvoq through AbbVie Patient Access Support. To check if you qualify, speak to a Rinvoq insurance specialist at 1-800-274-6867 Monday through Friday from 8:00 AM to 8:00 PM ET, except for holidays.
What if my pharmacy can’t process the Rinvoq copay card?
If you are not able to use the Rinvoq copay card at the pharmacy, you can still submit your receipt to receive a rebate for the amount you paid for your prescription. Just as the Rinvoq copay card, you must be eligible for these savings by having commercial insurance and a prescription for Rinvoq.
To submit your prescription or lab receipts for a rebate, you can do so online, in the RINVOQ Complete App, or by filling out a rebate form. You can find more information about Rinvoq rebates at https://www.rinvoq.com/resources/save-on-rinvoq-costs.
How much is Rinvoq without insurance?
The cost for Rinvoq 15 mg extended release oral tablet is around $6,895 for a supply of 30 tablets as of July 2025. For some conditions, this might be enough for a 30-day supply. However, you may be prescribed a higher dose or more tablets.
Prices can vary based on your location, pharmacy or any coupons you may have. The price of Rinvoq listed above is based on using the Rinvoq Price Guide and the Drugs.com discount card, which is accepted at most U.S. pharmacies. This price is not valid with an insurance plan.
Related questions
- What are the most common skin conditions? (with photos)
- What are the new drugs for rheumatoid arthritis (RA)?
- What are JAK inhibitors and how do they work?
How do I apply for the Rinvoq copay card?
You can apply for the Rinvoq copay card online, at https://www.rinvoq.com/sign-up. If you need help, you can call an insurance specialist at 1-800-274-6867 to discuss potential financial assistance that you may qualify to receive.
Key eligibility requirements include:
- Commercial insurance coverage (not government programs)
- Valid RINVOQ prescription for FDA-approved conditions
- Must not be enrolled in Medicare, Medicaid, TRICARE, or other federal programs
Some insurance plans implement "accumulator adjustment" or "co-pay maximizer" programs that can affect your savings card benefits. These programs prevent manufacturer assistance from counting toward your deductible and out-of-pocket maximums.
How These Programs Work:
- Accumulator programs: Copay assistance doesn't count toward annual deductibles or out-of-pocket limits
- Maximizer programs: Insurance sets copayment amounts to extract maximum value from manufacturer assistance
If your insurance implements these programs, you must call 1-800-2RINVOQ (1-800-274-6867) to discuss alternative support options. AbbVie monitors program utilization and may discontinue copay assistance if maximizer programs are detected.
Rinvoq Bridge Program
For patients experiencing insurance coverage delays or denials, the RINVOQ Complete Bridge Program provides free medication for up to 24 months. This program is available to eligible patients 63 years and younger with commercial insurance who have received an initial insurance denial.
Program benefits include:
- No charge for medication during the bridge period
- Coverage while appeals are processed
- Requires appeal documentation every 180 days
- Seamless transition once insurance approval is obtained
This is not all the information you need to know about Rinvoq (upadacitinib) for safe and effective use and does not take the place of your doctor’s directions. Pricing and coupon terms may change or vary significantly. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.
References
- Rinvoq. Abbvie. 2024. Accessed 10/22/2024 at https://www.rinvoq.com/resources/save-on-rinvoq-costs
- Rinvoq [package insert]. Updated April 2024. AbbVie Inc. Accessed 10/22/2024 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2966aec7-2ef0-923c-d8ff-fe1a957bf095
Read next
How do Rinvoq and Dupixent compare?
Rinvoq (upadacitinib) and Dupixent (dupilumab) differ significantly in how they work, their approved uses, side effect profiles, and cost structures.
Continue reading
Which JAK inhibitors are approved in the U.S?
List of JAK inhibitors approved in the United States include:
- Cibinqo (abrocitinib)
- Inrebic (fedratinib)
- Jakafi (ruxolitinib)
- Leqselvi (deuruxolitinib)
- Litfulo (ritlecitinib)
- Ojjaara (momelotinib)
- Olumiant (baricitinib)
- Opzelura (ruxolitinib)
- Rinvoq (upadacitinib)
- Vonjo (pacritinib)
- Xeljanz (tofacitinib)
What is the MOA and half-life for Rinvoq?
Rinvoq (upadacitinib) is an oral medicine that works by blocking intracellular Janus kinase (JAK) enzymes to help to reduce inflammation and pain in conditions such as rheumatoid arthritis. The half-life ranges from 8 to 14 hours and is the time it takes for half (50%) of the drug to be eliminated.
Continue readingSee also:
Related medical questions
- How long does Rinvoq stay in your system?
- What can I eat or drink with ulcerative colitis?
- Which is worse: Ulcerative colitis or Crohn's disease?
- How long do ulcerative colitis flare-ups last?
- What is the life expectancy of someone with ulcerative colitis?
- How often should I have a colonoscopy with ulcerative colitis?
- How effective are biologics for ulcerative colitis?
- What are the main causes of ulcerative colitis?
- How does Tremfya work?
- What's a good prednisone taper schedule?
- What are 7 mesalamine side effects to be aware of?
- What is Diprospan used for?
- Which is more effective, Beano or Gas-X for gas from ulcerative colitis?
- How much does Entyvio cost per month?
- What are IL-23 Inhibitors and how do they work?
- What are 7 key Stelara side effects to watch out for?
- Is Entyvio an immunosuppressant or a biologic?
- My stool has changed color. What does it mean?
- How long does it take Entyvio to start working?
- What's the dosing schedule for Skyrizi?
- Why is my poop green? What does this mean?
- How does Omvoh compare to Entyvio?
- How do you inject Humira?
- What is the mechanism of action of infliximab?
- Does Skyrizi cause cancer?
- Is Omvoh the same as Skyrizi?
- Can I take antibiotics while on Entyvio?
Drug information
- Rinvoq Information for Consumers
- Rinvoq prescribing info & package insert (for Health Professionals)
- Side Effects of Rinvoq (detailed)
- Rinvoq user reviews (245)
Related support groups
- Rinvoq (9 questions, 11 members)
- Ulcerative Colitis (79 questions, 188 members)
- Crohn's Disease (65 questions, 286 members)
- Psoriatic Arthritis (94 questions, 282 members)
- Ankylosing Spondylitis (61 questions, 212 members)
- Rheumatoid Arthritis (337 questions, 1,333 members)
- Atopic Dermatitis (49 questions, 54 members)
- Non-Radiographic Axial Spondyloarthritis (16 questions, 3 members)
- Polyarticular Juvenile Idiopathic Arthritis (4 questions, 3 members)